NFATC2 and sarcoma: In this study, the largest multi-omic assessment of EWSR1-NFATc2 fusion positive sarcomas to date, our data reinforces previous findings that EWSR1-NFATc2 fusion positive sarcomas are molecularly distinct from standard Ewing sarcomas.